Loomis Sayles Strategic Alpha Fund ELV Holdings History
Loomis Sayles Strategic Alpha Fund's Elevance Health Inc Holding Summary
As of 2025-03-31, Natixis Funds Trust II held 461.00 shares of Elevance Health Inc(ELV), totaling $200,520.00. This investment constitutes 1.81% of their stock portfolio, and Natixis Funds Trust II now holds 0% of the outstanding Elevance Health Inc(ELV) stock.
The initial trade took place in 2020Q1. And since then Loomis Sayles Strategic Alpha Fund has made 11 purchases of ELV, at an average price of $412.97, for a total of 4,979.00 shares. In addition, there have been 6 sales at an average price of $423.29 for 4,518.00 shares. Based on historical transaction data and ELV's current price of $276.45, Loomis Sayles Strategic Alpha Fund's estimated gain on his ELV holdings is $-16,269.42, reflecting a -0.79% gain to date.
Loomis Sayles Strategic Alpha Fund ELV ($276.45) Holding Chart
Loomis Sayles Strategic Alpha Fund ELV ($276.45) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
